Corindus Vascular Robotics Inc (CVRS) Upgraded to “Hold” at BidaskClub

Corindus Vascular Robotics Inc (NYSEMKT:CVRS) was upgraded by BidaskClub from a “sell” rating to a “hold” rating in a research note issued to investors on Thursday.

Other equities research analysts also recently issued reports about the stock. ValuEngine downgraded shares of Corindus Vascular Robotics from a “hold” rating to a “sell” rating in a report on Monday, July 17th. Zacks Investment Research raised shares of Corindus Vascular Robotics from a “hold” rating to a “buy” rating and set a $2.00 price target on the stock in a report on Tuesday, July 11th. Finally, B. Riley reissued a “buy” rating and issued a $3.00 price target on shares of Corindus Vascular Robotics in a report on Monday, May 15th.

Shares of Corindus Vascular Robotics (CVRS) opened at 1.66 on Thursday. The company’s market cap is $310.55 million. Corindus Vascular Robotics has a 12 month low of $0.40 and a 12 month high of $2.25. The stock’s 50 day moving average is $1.79 and its 200 day moving average is $1.25.

Corindus Vascular Robotics (NYSEMKT:CVRS) last announced its quarterly earnings results on Tuesday, August 8th. The medical equipment provider reported ($0.04) EPS for the quarter, beating the Zacks’ consensus estimate of ($0.05) by $0.01. The business had revenue of $2.26 million during the quarter, compared to analyst estimates of $3.10 million. Corindus Vascular Robotics had a negative net margin of 1,272.20% and a negative return on equity of 181.63%. On average, analysts anticipate that Corindus Vascular Robotics will post ($0.22) EPS for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: This story was posted by Ticker Report and is owned by of Ticker Report. If you are viewing this story on another publication, it was illegally stolen and republished in violation of U.S. & international trademark & copyright law. The correct version of this story can be viewed at https://www.tickerreport.com/banking-finance/2796665/corindus-vascular-robotics-inc-cvrs-upgraded-to-hold-at-bidaskclub.html.

A number of hedge funds and other institutional investors have recently modified their holdings of CVRS. Bank of New York Mellon Corp raised its stake in shares of Corindus Vascular Robotics by 6.3% in the first quarter. Bank of New York Mellon Corp now owns 163,012 shares of the medical equipment provider’s stock worth $214,000 after buying an additional 9,684 shares during the last quarter. Geode Capital Management LLC raised its position in shares of Corindus Vascular Robotics by 73.3% in the first quarter. Geode Capital Management LLC now owns 673,488 shares of the medical equipment provider’s stock valued at $882,000 after buying an additional 284,855 shares in the last quarter. Schwab Charles Investment Management Inc. raised its position in shares of Corindus Vascular Robotics by 240.4% in the first quarter. Schwab Charles Investment Management Inc. now owns 285,900 shares of the medical equipment provider’s stock valued at $375,000 after buying an additional 201,900 shares in the last quarter. Finally, Rhumbline Advisers raised its position in shares of Corindus Vascular Robotics by 67.6% in the second quarter. Rhumbline Advisers now owns 80,868 shares of the medical equipment provider’s stock valued at $150,000 after buying an additional 32,608 shares in the last quarter.

Corindus Vascular Robotics Company Profile

Corindus Vascular Robotics, Inc is engaged in robotic-assisted vascular interventions. The Company’s CorPath System is a medical device that brings robotic-assisted precision to radial, coronary and peripheral procedures. The workstation allows the physician greater control and the freedom from wearing heavy lead protective equipment that causes musculoskeletal injuries.

Receive News & Ratings for Corindus Vascular Robotics Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corindus Vascular Robotics Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

How to Trade on Forex – 8 Steps for Beginners
How to Trade on Forex – 8 Steps for Beginners
Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back


Leave a Reply

© 2006-2017 Ticker Report. Google+.